Royalty Pharma (NASDAQ:RPRX) reported quarterly earnings of $1.32 per share which beat the analyst consensus estimate of $1.28 by 3.13 percent. This is a 15.79 percent increase over earnings of $1.14 per share from the same period last year. The company reported quarterly sales of $674.000 million which missed the analyst consensus estimate of $693.190 million by 2.77 percent. This is a 16.41 percent increase over sales of $579.000 million the same period last year.